Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: M. Ramle who wrote (1228)	10/2/1998 12:44:00 PM
From: EyeDrMike	Read Replies (1) \| Respond to of 10280

Saw the CEO on CNBC. CNBC has been the kiss of death for many companies, it ran to 65 ran further to 72+ < shorted more at 70>, and covered today. Up too quick for a company that doesn't expect significant EPS til 2000+ I pulled the bookmark on the thread after i covered today. Any other questions, please pm me, or respond to my post here.

To: M. Ramle who wrote (1228)	10/5/1998 2:48:00 AM
From: M. Ramle	Respond to of 10280

To Teaburry22: I personally would NOT give this analyst at Bear Stearns any credibility for his downgrade, because his firm is not known to follow Biotechs as widely and as thoroughly as others such as Lehman Brothers, Morgan Stanley/DW and a few others. Having said that, I was very encouraged to see SEPR close at $61 7/8 last Friday, which was the low of Thursday's trading, and after having tested it's 50-DMA (~$58) twice last week, and bounced back to close above the previous high of $60 3/4. Therefore and on a technical basis, the uptrend chart has NOT been violated as of yet, and I don't expect it to do so unless the whole market sells off. I am still as much of a BULL as they could come and a very strong believer that the FDA would grant SEPR a wide approval on it's Levalbuterol applications very very shortly and that SEPR would sign up with Lilly on Prozac shortly after that. I have seen these ignorant analysts issue a downgrade one day with an upgrade reversal few days after that (and vice-versa for that matter) in order to serve and profit their big clients. Anybody with their common senses would clearly see that SEPR is an absolute screaming buy at these prices for the next 3-5 years. I for one, am using every opportunity I can get to add to my position at below $60. GOOD LUCK. Mazen